Our analysis demonstrated no significant differences in EGF, angiopoietin-2, endothelin-1, IL-8, VEGF-A, C, and D, FGF-2, and G-CSF between patients with and without PAD (Table 2). The gene discussed is FGF2; the disease is peripheral arterial disease.